Open AccessIntramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy
Author(s) -
Adam Williams,
Barry Trachtenberg,
Darcy L. Velazquez,
Ian McNiece,
Peter Altman,
Didier Rouy,
Adam Mendizabal,
Pradip M. Pattany,
Gustavo A. Lopera,
Joel E. Fishman,
Juan P. Zambrano,
Alan W. Heldman,
Joshua M. Hare
Publication year - 2011
Publication title -
circulation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.899
H-Index - 336
eISSN - 1524-4571
pISSN - 0009-7330
DOI - 10.1161/circresaha.111.242610
Subject(s) - medicine , cardiology , myocardial infarction , contractility , ventricular remodeling , ischemic cardiomyopathy , progenitor cell , bone marrow , cardiomyopathy , stem cell therapy , end diastolic volume , infarction , heart failure , bone marrow stem cell , cardiac function curve , stem cell , ejection fraction , transplantation , stroke volume , genetics , biology
Transcatheter, intramyocardial injections of bone marrow-derived cell therapy produces reverse remodeling in large animal models of ischemic cardiomyopathy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom